Literature DB >> 16538508

Successful OK-432 therapy for a supraclavicular lymphocele: report of a case.

Simon Florian Preuss1, Claus Wittekindt, Dirk Beutner, Karl-Bernd Huttenbrink.   

Abstract

Surgery is considered the gold standard in the treatment of lymphoceles, however this is not feasible for all cases. We report the successful treatment of a supraclavicular lymphocele by intralesional application of the sclerosing agent OK-432. After a total of three intralesional injections of OK-432, the cyst had disappeared completely and the patient was free of symptoms. Thus, intralesional application of OK-432 is considered a highly effective treatment for cystic masses such as lymphoceles.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16538508     DOI： 10.1007/s00405-006-0029-7

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN： 0937-4477            Impact factor:   2.503


  8 in total

1.  Experimental anticancer studies. XXXI. On the streptococcal preparation having potent anticancer activity.

Authors:  H Okamoto; M Minami; S Shoin; S Koshimura; R Shimizu
Journal:  Jpn J Exp Med       Date:  1966-04

2.  OK-432 therapy for lymphangioma in children: why and how does it work?

Authors:  S Ogita; T Tsuto; K Nakamura; E Deguchi; K Tokiwa; N Iwai
Journal:  J Pediatr Surg       Date:  1996-04       Impact factor: 2.545

3.  Efficacious pleurodesis with OK-432 and doxorubicin against malignant pleural effusions.

Authors:  K Kishi; S Homma; S Sakamoto; M Kawabata; E Tsuboi; K Nakata; K Yoshimura
Journal:  Eur Respir J       Date:  2004-08       Impact factor: 16.671

4.  OK-432 therapy for cervical lymphangioma.

Authors:  Jean-Yves Sichel; Raphael Udassin; David Gozal; Benjamin Z Koplewitz; Itszhak Dano; Ron Eliashar
Journal:  Laryngoscope       Date:  2004-10       Impact factor: 3.325

Review 5.  The past, the present and future of the OK-432 therapy for patients with malignant effusions.

Authors:  M Katano; T Morisaki
Journal:  Anticancer Res       Date:  1998 Sep-Oct       Impact factor: 2.480

6.  Bleomycin sclerotherapy in patients with congenital lymphatic malformation in the head and neck.

Authors:  M W Sung; S O Chang; J H Choi; J Y Kim
Journal:  Am J Otolaryngol       Date:  1995 Jul-Aug       Impact factor: 1.808

7.  Sclerotherapy for congenital lesions in the head and neck.

Authors:  Kwang Hyun Kim; Myung-Whun Sung; Jong-Lyel Roh; Moon Hee Han
Journal:  Otolaryngol Head Neck Surg       Date:  2004-09       Impact factor: 3.497

8.  OK-432 therapy in 64 patients with lymphangioma.

Authors:  S Ogita; T Tsuto; K Nakamura; E Deguchi; N Iwai
Journal:  J Pediatr Surg       Date:  1994-06       Impact factor: 2.545
  8 in total
  1 in total

Review 1.  Direct puncture sclerotherapy of a thoracic duct cyst presenting as an enlarging left supraclavicular mass.

Authors:  Yasha Kadkhodayan; Motoyo Yano; DeWitte T Cross
Journal:  BMJ Case Rep       Date:  2013-10-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.